NewsRoom Articles - Page 3 of 151 - PsychedelicNewsWire (PNW)

WednesdayOct 23, 2024 10:00 am

Researchers to Study Psychedelics, Empathogens in Quest for a PTSD Treatment

Post-traumatic stress disorder is a mental health disorder caused by an extremely terrifying or stressful event, either by an individual witnessing it or being a part of it. This disorder may last anywhere between months to years, with individuals experiencing intense physical and emotional reactions when the memories of trauma are unearthed by triggers. Estimates show that in the United Kingdom, 1 in 10 individuals will experience post-traumatic stress disorder in their lifetime. Currently, roughly 30% of patients who suffer from severe mental health conditions find that traditional therapies aren’t effective for them. Now a team of researchers in Cambridgeshire…

TuesdayOct 22, 2024 10:00 am

New Research Explores the Role of Psychedelic Trips in Healing

Interest in psychedelics has increased these last few years after numerous studies found that the drugs may possess therapeutic benefits. For instance, studies have found that ketamine could help reduce symptoms of depression and post-traumatic stress disorder while managing suicidal ideation. Studies also found that psilocybin could help manage symptoms of anxiety and depression, as well as post-traumatic stress disorder. Now new research has investigated the role that psychedelic trips play in healing, with a focus on psilocybin and ketamine. These drugs often induce profound subjective experiences when consumed, with scientists positing that these experiences may contribute to their therapeutic…

ThursdayOct 17, 2024 10:00 am

Producers Are Tweaking Psilocybin Mushrooms to Increase Potency

Research has shown that psychedelics may be useful in the treatment of various mental-health conditions, including post-traumatic stress disorder (PTSD) and depression. Now new methods of cultivation are making hallucinogenic mushrooms stronger, with their effects being felt by users faster and lasting longer. Julian Mattucci, commonly referred to as God Emperor Myco, recently revealed that he had tried about 1.5g of Psilocybe subtropicalis mushrooms. This dosage, which is considerably lower than the amount normally required to have a significant trip, was potent enough to have him lying in bed for three to four hours. Mattucci later tested the mushrooms, discovering…

TuesdayOct 15, 2024 10:00 am

Neuroscience Study Provides Insight into Psilocybin’s Impact on Spatial Awareness

Psilocybin is a psychedelic compound found in hundreds of species of hallucinogenic mushrooms. When ingested, the body converts the compound into psilocin, which is known to act on serotonin 2A receptors in the brain. Numerous studies have shown that psilocybin can alter an individual’s cognition, mood and perception when consumed. Research has also found that the psychedelic may cause profound changes to an individual’s sense of space, self and time. Now new research has looked into how this psychedelic affects activity in the brain and, particularly, its influence on individual neurons. For their research, the investigators studied mice that had…

ThursdayOct 10, 2024 10:00 am

Activists Consider Placing Psychedelic Decriminalization on 2026 State Ballot

Activists in Portland recently revealed that they were working to place a measure to decriminalize psychedelics on the 2026 ballot. The measure in question, called the Portland Psychedelic Health Act, would make the enforcement of laws against specific fungi and plant-based substances, including ayahuasca, psilocybin, DMT and mescaline, a low-enforcement priority in the city. It would also advocate for the decriminalization of psychedelics at the local level while also covering the possession, gifting and cultivation of natural psychedelics. In addition, the measure would establish an advisory panel focused on issuing guidance related to entheogens to the city. According to the…

TuesdayOct 08, 2024 10:00 am

Activists Say Tripping on Psychedelics Could Help Climate Change Fight

During Psychedelic Climate Week in New York, thousands gathered to promote climate solutions focused on phasing out fossil fuels in favor of cleaner energies. Various discussions were held during the event, with one focusing on how psychedelic experiences could spark shifts in consciousness and help inspire behaviors that were more climate friendly. This was one of the features of Climate Week, with other events including a performance by a rag wrestling collective, several climate-themed discussions, meditation and dancing. This comes as the general public grows more anxious about the climate crisis given the slowly increasing global temperatures and the frequency…

ThursdayOct 03, 2024 10:00 am

Study Suggests Psychedelics Combat Anxiety by Exciting Cells in Hippocampus

Numerous studies have found that psychedelics hold the potential to treat mental-health conditions, including anxiety, depression and post-traumatic stress disorder. Now new research has found that psychedelics activate cells in the brain that help reduce anxiety. The research was conducted by a global team of investigators, including at the Tata Institute of Fundamental Research and Cornell University. The researchers’ focus was on determining what types of cells and areas in the brain were involved when anxiety was suppressed using psychedelics. Associate professor Alex Kwan, the study’s senior author, explained that knowing the neurobiology involved would assist in the development of…

TuesdayOct 01, 2024 10:05 am

DEA Ramps Up Production of Psychedelics for Research Purposes

The U.S. Drug Enforcement Administration (DEA) recently announced new production quotas for controlled substances under schedules 1 and 2. The new quotas show increases in the supply of psychedelics such as ibogaine, psilocybin and psilocyn, which the federal agency notes shall be used for research purposes. Specifically, the 2024 quotas for psilocyn and psilocybin have risen to 36,000 grams and 30,000 grams respectively. Ibogaine’s quota has also risen, from 150 grams to 210 grams, to help meet the increasing demand for research. The agency’s increased focus on the production of psychedelics comes at a time when more anecdotal reports and…

ThursdaySep 26, 2024 10:00 am

Parsons Foundation Makes Major Donation to Mount Sinai Psychedelics Center

Last week, Mount Sinai Health System announced that it had received a $5 million donation from the Bob & Renee Parsons Foundation, which changed its name to the Parsons Research Center for Psychedelic Healing. This follows the expansion of its psychedelic research center to a new location focused on supporting the center’s capacity to assist in clinical trials that involve compounds such as psilocybin, ketamine and MDMA, among others. These drugs have attracted a lot of attention in research for their potential in helping manage symptoms of mental-health conditions such as anxiety, depression and PTSD. The gift will also facilitate…

TuesdaySep 24, 2024 10:00 am

Expert Explains Why Psychedelic Microdosing Could Transform Productivity

Microdosing is the practice of consuming low doses of psychedelic substances such as psilocybin mushrooms or LSD. This allows an individual to gain the benefits of the drugs without experiencing any psychoactive effects. Peggy Van de Plassche, a microdosing expert and author, recently discussed the benefits of microdosing and the stigma surrounding psychedelics on the Future of Work podcast. Van de Plassche’s personal journey with psychedelics, which started as a quest to improve her mental health, greatly influenced her current path. Her experience with psychedelics caused significant positive changes in her mental well-being, leading her to advocate for psychedelics integration…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000